Alkan, A. Et Al. 2016. Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxelcisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer. 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , (Copenhagen, Denmark).

Alkan, A., Mizrak, D., Karci, E., Yasar, A., Koksoy, E. B., Urun, M., ... Kutuk, T.(2016). Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxelcisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer . 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark

Alkan, A. Et Al. "Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxelcisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer," 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark, 2016

Alkan, A. Et Al. "Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxelcisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer." 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , Copenhagen, Denmark, 2016

Alkan, A. Et Al. (2016) . "Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxelcisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer." 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , Copenhagen, Denmark.

@conferencepaper{conferencepaper, author={A. Alkan Et Al. }, title={Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxelcisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer}, congress name={41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Copenhagen}, country={Denmark}, year={2016}}